Navigation Links
Mr. Ronald L. Chez Filed Amended 13D for RepliGen Corporation

CHICAGO, June 22, 2011 /PRNewswire/ -- Amended 13D for RepliGen Corporation was filed with the SEC by Mr. Ronald L. Chez, a private investor.

Mr. Ronald L. Chez is the President of Ronald L. Chez, Inc., and a private investor.

RepliGen Corporation is a biopharmaceutical company focused on building an integrated company by developing and marketing innovative drugs that deliver the benefits of protein therapies in the fields of neurology and gastroenterology.  RepliGen has a core competency in the development and manufacturing of biologics products, which is the basis for its bioprocessing business and RepliGen has out-licensed certain biologics intellectual property, which provide ongoing sources of revenue. Corporate headquarters are located at 41 Seyon Street, Waltham, Massachusetts 02453.

Inquiry Contact:
Barry Fischer
(312) 580-2233

SOURCE Ronald L. Chez
Copyright©2010 PR Newswire.
All rights reserved

Page: 1

Related medicine technology :

1. Cardiac Science Appoints Healthcare Executive Ronald A. Andrews, Jr. to Board of Directors
2. Keppra XR(TM) Extended-Release Tablets Filed with the FDA
3. Parker Waichman Alonso LLP and Affiliated Lawfirms Have Filed a Class Action Lawsuit in the United States District Court for the Eastern District of New York Against Merck & Co., Inc. and Schering-Plough Corporation
4. Shareholder Class Action Filed Against Vertex Pharmaceuticals Incorporated by the Law Firm of Schiffrin Barroway Topaz & Kessler, LLP
5. Shareholder Class Action Filed Against Rigel Pharmaceuticals, Inc. by the Law Firm of Barroway Topaz Kessler Meltzer & Check, LLP
6. Shire has Filed a Treatment Protocol for Velaglucerase Alfa for Gaucher Disease
7. Shareholder Class Action Filed Against SciClone Pharmaceuticals, Inc. by the Law Firm of Barroway Topaz Kessler Meltzer & Check, LLP
8. Class Action Lawsuit Filed Against DePuy Orthopaedics, Inc.
9. DePuy Recalled Hip Device Lawsuit Filed in East Texas
10. DePuy Recalled Hip Device Lawsuit Filed in San Antonio, Texas
11. DePuy Recalled Hip Device Lawsuit Filed in Austin, Texas
Post Your Comments:
(Date:11/26/2015)... , November 26, 2015 ... the addition of the  "2016 Future ... European Therapeutic Drug Monitoring (TDM) Market: ... Intelligence, Emerging Opportunities"  report to their ... has announced the addition of the  ...
(Date:11/26/2015)... , November 26, 2015 ... of the "Radioimmunoassay Market by Type ... Pharmaceutical Industry, Academics, Clinical Diagnostic Labs), Application ... Forecast to 2020" report to their ... announced the addition of the "Radioimmunoassay ...
(Date:11/25/2015)...  Amgen (NASDAQ: AMGN ) today announced the ... the United States (U.S.) Food and ... to Humira ® (adalimumab). Amgen believes this submission ... FDA and represents Amgen,s first BLA submission using the ... M.D., executive vice president of Research and Development at ...
Breaking Medicine Technology:
(Date:11/26/2015)... ... November 26, 2015 , ... ... eReferral system for diagnostic imaging in the Waterloo region. Using the Ocean Platform, ... Medicine tests directly from their electronic medical record (EMR) without the need for ...
(Date:11/26/2015)... (PRWEB) , ... November 26, 2015 , ... ... of workshops to discuss bioavailability and the need to integrate dose form selection ... in collaboration with OBN, the membership organization supporting and bringing together the UK’s ...
(Date:11/26/2015)... (PRWEB) , ... November 26, 2015 , ... PRMA Plastic ... November 19, 2015, our surgeons performed their 6,000th free flap breast reconstruction surgery! , ... wake up every day excited to rebuild lives and it’s an honor to have ...
(Date:11/26/2015)... ... November 26, 2015 , ... Pixel Film Studios brings Final ... ProTrailer: Vintage. This newly styled ProTrailer pack comes with 30 all-new vintage-inspired designs, ... giving users limitless opportunities to stylize and create designs quickly and easily, all ...
(Date:11/26/2015)... ... November 26, 2015 , ... Indosoft Inc., developer and distributor of the ... to improve system efficiency and reliability. , The new Q-Suite 6 platform is based ... system avoids locking itself into a specific piece of software for many key components ...
Breaking Medicine News(10 mins):